ArticleSchizophrenia (Heidelberg, Germany)2025
Characteristics of real-world driving behavior in people with schizophrenia: a naturalistic study utilizing drive recorders.
Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Driving Profile of Individuals with Schizophrenia: Cognitive Characteristics, Pharmacological Treatment and Driving Competence-A Scoping Review.Neurology international · 2026Review
- Sequential Fixation Behavior in Road Marking Recognition: Implications for Design.Journal of eye movement research · 2025Article
- Driving Performance in Schizophrenia: The Role of Neurocognitive Correlates-A Systematic Review.Brain sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research on driving among people with schizophrenia (PWS) is limited to laboratory-based studies. The present study aimed to compare PWS with healthy controls (HC) in real-world driving behaviors using 500 km of driving data collected through dashcams. Neuropsychological tests were conducted to evaluate both PWS and HC. After the evaluation, we compared traffic violations with dangerous driving behaviors, such as sudden braking and abrupt steering. PWS were treated with antipsychotics and antiparkinsonians and were evaluated using the Positive and Negative Syndrome Scale (PANSS) and the Drug-Induced Extrapyramidal Symptoms Scale. Statistical analysis included factor analysis, which was employed to evaluate the classification of violations and driving behaviors; correlation coefficients were employed to evaluate actual driving behavior. The results indicated that the mean driving speed was significantly lower, instances of speeding were absent, and the frequency of inhibition-related driving violations, such as smartphone use while driving, was lower. Violations related to inattention were associated with sustained attention and the useful field of view (UFOV). These findings suggest that PWS are less likely to engage in reckless driving compared to HC. Furthermore, considering that driving violations among PWS may be attributed to cognitive errors, the results highlight the importance of assessing and addressing cognitive functions in driver assistance systems to promote safer driving. One limitation of the study was that the severity of psychopathology among the participants was relatively low, which may have contributed to the PANSS, its subscales, and factors being less predictive of traffic violations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.